You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 1, January 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pituitary Tumors and Hyperprolactinemia

William B. Malarkey, MD; John C. Johnson, MD

Arch Intern Med. 1976;136(1):40-44.


Abstract

Hyperprolactinemia was demonstrated in eight of nine patients with clinical evidence of pituitary tumors without acromegaly or Cushing syndrome. Hourly sampling for 24 hours disclosed elevation of serum prolactin concentrations, whereas, measurable serum growth hormone levels were found rarely. Although eight of these patients were hypersecreting prolactin, only four of them were lactating. Prolactin secretion was characterized by moderate hourly fluctuations of serum levels and absence or blunting of the normal sleep-related augmentation of secretion. Patients with the highest serum prolactin concentrations tended to have the largest pituitary tumors, as indicated by pneumoencephalography. In two patients followedup with serum prolactin determinations after treatment, a fall in serum prolactin concentrations correlated with clinical improvement. Future study will hopefully establish the value of serum prolactin determinations in following tumor growth before and after pituitary ablative therapy.

(Arch Intern Med 136:40-44, 1976)



Author Affiliations

From the departments of medicine and radiology, Ohio State University Hospitals, Columbus.


Footnotes

Received for publication March 11, 1975; accepted June 27.

Reprint requests to Ohio State University Hospital, 410 W Tenth Ave, Columbus, OH 43210 (Dr Malarkey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Persistence of Macroprolactinemia Due to Antiprolactin Autoantibody before, during, and after Pregnancy in a Woman with Systemic Lupus Erythematosus
Leanos-Miranda et al.
J. Clin. Endocrinol. Metab. 2001;86:2619-2624.
ABSTRACT | FULL TEXT  

Elevated Serum Prolactin Level in the Zollinger-Ellison Syndrome
Stabile et al.
Arch Surg 1981;116:449-453.
ABSTRACT  

Hyperprolactinemia in Multiple Endocrine Adenomatosis, Type 1
Carlson et al.
Arch Intern Med 1978;138:1807-1808.
ABSTRACT  

The Invasive Pituitary Adenoma: A Prolactin-Producing Tumor
Lundberg et al.
Arch Neurol 1977;34:742-749.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.